How can pharmaceutical companies ensure that trials proceed in a timely and cost-effective manner?
Beth Harper. Assuming a well-designed protocol is in place, two critical success factors are selecting the right sites for the study and setting them up for success. An overhaul of the traditional approach to site selection, feasibility assessments, recruitment planning and site training processes is needed to ensure that investigative sites, the suppliers of the subjects and data, have not only the experience and capabilities but the interest, resources, infrastructure, willingness and commitment to conduct the trial. This involves going way beyond the typical and often perfunctory transactions with the sites and adopting a true collaboration mindset to partner with our site suppliers in new and different ways. NGP. How have methods of patient enrolment/recruitment changed in the last few years? BH. Technologies such as web-based recruitment techniques and electronic health records that facilitate more efficient patient identification and pre-screening have emerged in the last several
- Why would international or Australian pharmaceutical companies place their trials in Australia when there are providers of the same services in the US?
- Why do pharmaceutical companies increasingly shift their clinical drug trials to developing countries?
- How can pharmaceutical companies ensure that trials proceed in a timely and cost-effective manner?